⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001989954

Perlich Irene

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

Transactions

14

Companies

1

Filings

3

CIK

0001989954

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-04-05	NGM BIOPHARMACEUTICALS INCU Disposition from Tender	Principal Accounting Officer	UDisposition from Tender	−6,284 sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCRestricted Stock UnitD Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−7,500 sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−50K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−35K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−17.5K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−30K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−20K sh	—	—	0
2024-01-16	NGM BIOPHARMACEUTICALS INCF Tax Payment	Principal Accounting Officer	FTax Payment	−1,025 sh	$1.34	−$1,373.5	8,975
2023-11-06	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Principal Accounting Officer	AAward	+50K sh	—	—	50,000
2023-11-06	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−50K sh	—	—	0
2023-11-06	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Principal Accounting Officer	AAward	+35K sh	—	—	35,000
2023-11-06	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−35K sh	—	—	0
2023-11-06	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Principal Accounting Officer	AAward	+17.5K sh	—	—	17,500
2023-11-06	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−17.5K sh	—	—	0

Recent filings

3

Accepted (ET)
Apr 84
Perlich Irene0000950170-24-042607
SEC(opens sec.gov)
Jan 184
Perlich Irene0001415889-24-001543
SEC(opens sec.gov)
Nov 84
Perlich Irene0001209191-23-054734
SEC(opens sec.gov)

Companies

1

NGM BIOPHARMACEUTICALS INCPrincipal Accounting Officer

Address

C/O NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080